Horizon Pharma plc to Participate in Upcoming Conferences

DUBLIN, Ireland, May 26, 2017 (GLOBE NEWSWIRE) -- Horizon Pharma plc (Nasdaq: HZNP), a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs, announced today that the company will participate at the following conferences in June:

Jefferies 2017 Global Healthcare Conference

• Date: June 6, 2017
• Presentation Time: 11:30 a.m. ET
• Location: New York, NY

The JMP Securities Life Science Conference

• Presentation Date: June 21, 2017
• Presentation Time: 1:30 p.m. ET
• Location: New York, NY

The conferences presentations will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizon-pharma.com.   About Horizon Pharma plc Horizon Pharma plc is a biopharmaceutical company focused on improving patients' lives by identifying, developing, acquiring and commercializing differentiated and accessible medicines that address unmet medical needs.  The Company markets 11 medicines through its orphan, rheumatology and primary care business units.  For more information, please visit www.horizonpharma.com.  Follow @HZNPplc on Twitter or view careers on our LinkedIn page.

Contacts:

You May Also Be Interested In

• INNMI Peptide Continues to Expand Peptide Product Portfolio, Strengthening Global Market Reach and Production Service Capabilities
• XRP’s $50 Debate and HYPE’s SEC Push Set the Stage for Apeing, the Upcoming Crypto Coin Making Waves Ahead of Its Presale 
• Record results for Kinepolis in the first half of the year